Department of Chemistry, McGill University, 801 Sherbrooke St. W., Montréal, Québec, H3A0B8, Canada.
Department of Chemistry, McGill University, 801 Sherbrooke St. W., Montréal, Québec, H3A0B8, Canada.
Eur J Med Chem. 2020 Jun 1;195:112270. doi: 10.1016/j.ejmech.2020.112270. Epub 2020 Mar 30.
Research related to boronic acids, from synthetic development to materials to drug discovery, has skyrocketed in the past 20 years. In terms of drug discovery, the incorporation of boronic acids into medicinal chemistry endeavours has seen a steady increase in recent years. In fact, the Food and Drug Administration (FDA) and Health Canada have thus far approved five boronic acid drugs, three of which were approved in the past four years, and several others are in clinical trials. Boronic acids have several desirable properties that has led to their increased use, including potentially enhancing potency of drugs and/or improving their pharmacokinetics profile. This review explores discovery processes of boronic acid drugs. It begins with a brief scope of boron in natural products and in current drugs, followed by an investigation into the various rationalizations for boronic acid incorporation and the synthetic developments that focused on facilitating their addition into organic compounds. We hope that the knowledge we have assembled in this literature review will encourage medicinal chemists to consider the potential benefits of incorporating boronic acids into their future drug discovery endeavours.
硼酸相关研究,从合成开发到材料再到药物发现,在过去 20 年中呈爆炸式增长。在药物发现方面,近年来硼酸在药物化学领域的应用稳步增加。事实上,美国食品和药物管理局(FDA)和加拿大卫生部迄今已批准了五种硼酸药物,其中三种是在过去四年内批准的,还有几种正在临床试验中。硼酸具有一些理想的特性,这导致了它们的使用增加,包括可能提高药物的效力和/或改善其药代动力学特性。本文探讨了硼酸药物的发现过程。它首先简要介绍了硼在天然产物和现有药物中的应用,然后调查了硼酸结合的各种合理化以及专注于促进其加入有机化合物的合成发展。我们希望,我们在这篇文献综述中收集的知识将鼓励药物化学家考虑将硼酸纳入其未来药物发现工作的潜在益处。